VBIO stock forecast
Our latest prediction for Vitality Biopharma, Inc.'s stock price was made on the March 29, 2019 when the stock price was at 0.50$.
In the short term (2weeks), VBIO's stock price should outperform the market by 6.10%. During that period the price should oscillate between -8.21% and +18.92%.
In the medium term (3months), VBIO's stock price should outperform the market by 9.56%. During that period the price should oscillate between -19.31% and +53.19%.Get email alerts
About Vitality Biopharma, Inc.
Vitality Biopharma, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. The Clinical Operations segment focuses on treating patients suffering from addiction and dependency. The Pharmaceutical Operations segment engages in research and development primarily related to the Company's cannabinoid pharmaceuticals. The company was founded by Avtar S. Dhillon and Robert T. Brooke on June 29, 2007 and is headquartered in Los Angeles, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.18$ per share.
The book value per share is 0.30$
Three months stock forecastMarch 29, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|